Arvinas (ARVN) Operating Income (2017 - 2026)

Arvinas' (ARVN) quarterly Operating Income came in at -$63.8 million in Q1 2026, down 189.36% year-on-year from $71.4 million in Q1 2025, and up 14.48% quarter-over-quarter from -$74.6 million in Q4 2025.

Arvinas (ARVN) Operating Income (2017 - 2026) Analysis & Trends

Arvinas' Operating Income history runs 10 years deep, the most recent figure standing at -$63.8 million for Q1 2026.

  • On a quarterly basis, Operating Income fell 189.36% year-over-year to -$63.8 million in Q1 2026; TTM through Mar 2026 was -$253.7 million, a 165.38% decrease from a year earlier, with the FY2025 full-year figure at -$118.5 million, up 52.64% from the prior year.
  • Operating Income climbed to -$63.8 million in Q1 2026 per ARVN's latest filing, from -$74.6 million in the prior quarter.
  • Across five years, Operating Income topped out at $71.4 million in Q1 2025 and bottomed at -$165.3 million in Q4 2023.
  • The 5-year median for Operating Income is -$65.8 million (2022), against an average of -$64.6 million.
  • Across the five-year window, Operating Income jumped 185.71% in 2025 and slumped 189.36% in 2026, its largest moves.
  • Year by year, Operating Income stood at -$75.6 million in 2022, then slumped by 118.65% to -$165.3 million in 2023, then soared by 64.79% to -$58.2 million in 2024, then decreased by 28.18% to -$74.6 million in 2025, then advanced by 14.48% to -$63.8 million in 2026.
  • Per Business Quant, the three latest ARVN Operating Income figures stand at -$63.8 million (Q1 2026), -$74.6 million (Q4 2025), and -$43.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -27.75 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 249.90 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.14 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 642.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 394.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -445.22 Mn
10 Arvinas 512.64 Mn -102.26 Mn - -63.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -63.80 Mn
Dec 31, 2025 -74.60 Mn
Sep 30, 2025 -43.80 Mn
Jun 30, 2025 -71.50 Mn
Mar 31, 2025 71.40 Mn
Dec 31, 2024 -58.20 Mn
Sep 30, 2024 -60.30 Mn
Jun 30, 2024 -48.50 Mn
Mar 31, 2024 -83.30 Mn
Dec 31, 2023 -165.30 Mn
Sep 30, 2023 -73.90 Mn
Jun 30, 2023 -74.60 Mn
Mar 31, 2023 -87.70 Mn
Dec 31, 2022 -75.60 Mn
Sep 30, 2022 -64.30 Mn
Jun 30, 2022 -65.80 Mn
Mar 31, 2022 -57.70 Mn
Dec 31, 2021 -47.50 Mn
Sep 30, 2021 -47.30 Mn
Jun 30, 2021 -51.90 Mn